🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Twist Bioscience Corporation

TWST Healthcare
$142.39 +$26.29 (22.64%)
Market Cap: $8.93 B
Gurus Holding
5
Popularity Rank
#1701
% of Shares Held
7.55%
Net Activity (Q2 2026)
-$220.15 M

Guru Ownership Trend

Guru Analysis for Twist Bioscience Corporation (TWST)

Twist Bioscience Corporation (TWST), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $673.81 M.

Top institutional holders include Catherine Wood and Cliff Asness.

Institutional sentiment is currently Bearish. This is evidenced by a $220.15 M net outflow during the quarter.

Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Catherine Wood reduced exposure by 28.3%.

Key Holders

Top 5 by Value

$468.08 M
$13.31 M
$1.92 M
$326,027

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$5.92 M
Total Buy Value
New Buys 3
Additions 1
-$226.07 M
Total Sell Value
Reductions 1
Sold Out 2

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
4

FAQs for Twist Bioscience Corporation (TWST)

Major holders include Catherine Wood ($468.08 M), Cliff Asness ($13.31 M), Paul Tudor Jones ($3.2 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 4.73 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $220.15 M, with 4 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited TWST. The total reported sell value was $226.07 M.

Yes, 3 managers opened new positions in TWST, and 1 increased their existing holdings. The total reported buy value was $5.92 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
3.04% Reduce -28.3% 4,549,803 $468.08 M Q2 2026
0.00% Add 3.7% 129,391 $13.31 M Q2 2026
0.00% New Buy 31,109 $3.2 M Q2 2026
0.01% New Buy 18,647 $1.92 M Q2 2026
0.00% New Buy 3,169 $326,027 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form